Role of integrins in angiogenesis

European Journal of Cancer Part A

Volumn 32, Issue 14, 1996, Pages 2423-2429

  Brooks, P C ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; ENDOTHELIAL CELL GROWTH FACTOR; INTEGRIN; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; CELL ADHESION; CELL PROLIFERATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW;

EID: 0030484702     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00381-4     Document Type: Article

References (67)

1. 1. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992, 267, 10931-10934.
2. 2. Blood CH, Zetter BR. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1990, 1032, 89-118.
3. 3. Fidler IJ, ElHs LM. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994, 79, 185-188.
4. 4. Paku S, Paweletz N. First steps of tumor-related angiogenesis. Lab Invest 1991, 65, 334-346.
5. 5. Leek RD, Harris AL, Lewis CE. Cytokine networks in solid human tumors: regulation of angiogenesis. J Leuk Biol 1994, 56, 423-435.
6. 6. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C. Macrophages and angiogenesis. J Leuk Biol 1994, 55, 410-422.
7. 7. Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood-island formation and vasculogenesis in FLK-1-deficient mice. Nature 1995, 376, 62-66.
8. 8. Fong G-H, Rossant J, Gertsenstein M, Breltman ML. Role of the Fit-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995, 376, 66-69.
9. 9. Mustonen T, Alitalo K. Endothelial receptor tyrosine kinase involved in angiogenesis. J Cell Biol 1995, 129, 895-898.
10. 10. Sato TN, Tozawa Y, Deutsch U, et al. Distinct roles of the receptor tyrosine kinase Tie-1 and Tie-2 in blood vessel formation. Nature 1995, 376, 70-74.
11. 11. Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 1995, 376, 517-519.
12. 12. Hynes RO. Integrins. Versatility, modulation, and signaling in cell adhesion. Cell 1992, 69, 11-25.
13. 13. Nguyen M, Strubel NA, Bischoff J. A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis. Nature 1993, 365, 267-269.
14. 14. Brooks PC, Stromblad S, Sanders LC, et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 1996, 85, 683-693.
15. 15. Stetler-Stevenson WG. Dynamics of matrix turnover during pathologic remodelling of the extracellular matrix. Am J Pathol 1996, 148, 1345-1350.
16. 16. Fisher C, Gilbertson-Beadling S, Powers EA, Petzold G, Poorman R, Mitchell MA. Interstitial collagenase is required for angiogenesis in vitro. Dev Biol 1994, 162, 499-510.
17. 17. Pepper MS, Belin D, Montesano R, Orci L, Vassalli J-D. Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol 1990, 111, 743-755.
18. 18. Sage HE, Bernstein P. Extracellular proteins that modulate cell-matrix interactions. J Biol Chem 1991, 266, 14831-14834.
19. 19. Basson CT, Kocher O, Basson MD, Asis A, Madri JA. Differential modulation of vascular cell integrin and extracellular matrix expression in vitro by TGF-β1 correlates with reciprocal effects on cell migration. J Cell Physiol 1992, 153, 118-128.
20. 20. Form DM, Pratt BM, Madri JA. Endothelial cell proliferation during angiogenesis. Lab Invest 1986, 55, 521-530.
21. 21. Luscinskas FW, Lawler J. Integrins as dynamic regulators of vascular function. FASEB J 1994, 8, 929-938.
22. 22. Nicosia RF, Madri JA. Microvascular extracellular matrix. Am J Pathol 1987, 128, 78-90.
23. 23. Carey DJ. Control of growth and differentiation of vascular cells by extracellular matrix proteins. Annu Rev Physiol 1991, 53, 161-177.
24. 24. Risau W, Lemmon V. Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. Dev Biol 1988, 125, 441-450.
25. 25. Iruela-Arispe ML, Hasselaar P, Sage H. Differential expression of extracellular proteins is correlated with angiogenesis in vitro. Lab Invest 1991, 64, 174-186.
26. 26. Clark RAF, DellaPelle P, Manseau E, Lanigan JM, Dvorak HF, Colvin RB. Blood vessel fibronectin increases in conjunction with endothelial cell proliferation and capillary ingrowth during wound healing. J Invest Dermatol 1982, 79, 269-276.
27. 27. Myers JC. Differential expression of type I collagen and cellular fibronectin isoforms in endothelial cell variants. Kidney Int 1993, 43, 45-52.
28. 28. Ruoslahti E. Integrins. J Clin Invest 1991, 87, 1-5.
29. 29. Lester BR, McCarthy JB. Tumor cell adhesion to the extracellular matrix and signal transduction mechanisms implicated in tumor cell motility, invasion and metastasis. Cancer Met Rev 1992, 31-44.
30. 30. Montgomery AMP, Reisfeld RA, Cheresh DA. Integrin αvβ3 rescues melanoma cells from apoptosis in a three-dimensional dermal collagen. Proc Natl Acad Sci USA 1994, 91, 8856-8860.
31. 31. Miyamoto S, Teramoto H, Coso OA, et al. Integrin function: molecular hierarchies of cytoskeletal and signaling molecules. J Cell Biol 1995, 131, 791-805.
32. 32. Sastry SK, Horwitz A. Integrin cytoplasmic domains: mediators of cytoskeletal linkages and extra-and intracellular initiated transmembrane signaling. Curr Opin Cell Biol 1993, 5, 819-831.
33. 33. Yamada KM, Miyamoto S. Integrin transmembrane signaling and cytoskeletal control. Curr Opin Cell Biol 1995, 7, 681-689.
34. 34. Damsky CH, Werb Z. Signal transduction by integrin receptors for extracellular matrix: cooperative processing of extracellular information. Curr Opin Cell Biol 1992, 4, 772-781.
35. 35. Polverini PJ. Cellular adhesion molecules: newly identified mediators of angiogenesis. Am J Pathol 1996, 148, 1023-1029.
36. 36. Enenstein J, Walesh NS, Kramer RH. Basic FGF and TGF-β differentially modulate integrin expression of human microvascular endothelial cells. Exp Cell Res 1992, 203, 499-503.
37. 37. Sepp NT, Li L-J, Lee KH, et al. Basic fibroblast growth factor increases expression of the αvβ3 integrin complex on human microvascular endothelial cells. J Invest Dermatol 1994, 103, 295-299.
38. 38. Swerlick RA, Brown EJ, Xu Y, Lee KH, Manos S, Lawley TJ. Expression and modulation of vitronectin receptor on human dermal microvascular endothelial cells. J Invest Dermatol 1992, 99, 715-722.
39. 39. Enenstein J, Kramer RH. Confocal microscopic analysis of integrin expression on the microvascular and its sprouts in the neonatal foreskin. J Invest Dermatol 1994, 103, 381-386.
40. 40. Brooks PC, Clark RAF, Cheresh DA. Requirement of vascular integrin αvβ3 for angiogenesis. Science 1994, 264, 569-571.
41. 41. Brooks PC, Montgomery AMP, Rosenfeld M, et al. Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994, 79, 1157-1164.
42. 42. Clark RAF, Tonnesen MG, Gailit J, Cheresh DA. Transient functional expression of αvβ3 on vascular cells during wound repair. Am J Pathol 1996, 148, 1407-1421.
43. 43. Bauer J, Margolis M, Schreiner C, et al. In vitro model of angiogenesis using a human endothelium-derived permanent cell line; contributions of induced gene expression, G-proteins, and integrins. J Cell Physiol 1992, 153, 437-449.
44. 44. Davis CM, Danehower SC, Laurenza A, Molony JL. Identification of a role of the vitronectin receptor and protein kinase C in the induction of endothelial cell vascular formation. J Cell Biochem 1993, 51, 206-218.
45. 45. Yang JT, Ruburn H, Hynes RO. Embryonic mesodermal defects in α5 integrin-deficient mice. Development 1993, 119, 1092-1105.
46. 46. Grant DS, Tashiro K-I, Segui-Real B, Yamada Y, Martin GR, Kleinman HK. Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell 1989, 58, 933-943.
47. 47. Schnaper HW, Kleinman HK, Grant DS. Role of laminin in endothelial cell recognition and differentiation. Kidney Int 1993, 43, 20-25.
48. 48. Davis GE, Camarillo CW. An α2β1 integrin-dependent pinocytic mechanism involving intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional collagen matrix. Exp Cell Res 1996, 224, 39-51.
49. 49. Drake CJ, Davis LA, Little CD. Antibodies to β1-integrins cause alterations of aortic vasculogenesis in vivo. Dev Dynamics 1991, 193, 83-91.
50. 50. Van Der Rest M, Garrone R. Collagen family of proteins. FASEB J 1991, 5, 2814-2823.
51. 51. Lohler J, Timpl R, Jaeniosch R. Embryonic lethal mutation in mouse collagen I gene causes rupture of blood vessels and is associated with erythopoietic and mesenchymal cell death. Cell 1984, 38, 597-607.
52. 52. Ingber D, Folkman J. Inhibition of angiogenesis through modulation of collagen metabolism. Lab Invest 1988, 56, 44-51.
53. 53. Haralabopoulos GC, Grant DS, Kleinman HK, Lelkes PI, Papaioannou SP, Maragoudakis ME. Inhibitors of basement membrane collagen synthesis prevent endothelial cell alignment in matrigel in vitro and angiogenesis in vivo. Lab Invest 1994, 71, 575-582.
54. 54. Huhtala P, Humphries MJ, McCarthy JB, Tremble PM, Werb Z, Damsky CH. Cooperative signaling by α5β1 and α4β1 integrins regulates metalloproteinase gene expression in fibroblast adhering to fibronectin. J Cell Biol 1995, 129, 867-879.
55. 55. Moses MA, Suahlter J, Langer R. Identification of an inhibitor of neovascularization from cartilage. Science 1990, 248, 1409-1412.
56. 56. Kubota Y, Kleinman HK, Martin GR, Lawley TJ. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol 1988, 107, 1589-1598.
57. 57. Nicosia RF, Bonanno E. Inhibition of angiogenesis in vitro by Arg-Gly-Asp-containing synthetic peptide. Am J Pathol 1991, 138, 829-833.
58. 58. Gamble JR, Matthias LJ, Meyers G, et al. Regulation of in vitro capillary tube formation by anti-integrin antibodies. J Cell Biol 1993, 121, 931-943.
59. 59. Ingber DE, Folkman J. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. J Cell Biol 1989, 109, 317-330.
60. 60. Felding-Habermann B, Ruggeri ZM, Cheresh DA. Distinct biological consequences of integrin αvβ3-mediated melanoma cell adhesion to fibrinogen and its plasmic fragments. J Biol Chem 1992, 267, 5070-5077.
61. 61. Brooks PC, Stromblad S, Klemke R, Visscher D, Sarkar FH, Cheresh DA. Antiintegrin αvβ3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest 1995, 96, 1815-1822.
62. 62. Hammes H-p, Brownlee M, Jonczyk A, Sutter A, Preissner KT. Subcutaneous injection of a cyclic peptide antagonsist of vitronectin receptor-type integrins inhibit retinal neovascularization. Nature Med 1996, 2, 529-533.
63. 63. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA. Definition of two angiogenic pathways by distinct αv integrins. Science 1995, 270, 1500-1502.
64. 64. Drake CJ, Cheresh DA, Little CD. An antagonist of integrin αvβ3 prevents maturation of blood vessels during embryonic neovascularization. J Cell Sci 1995, 108, 2655-2661.
65. 1WAF1/CIP1 expression by vascular cell integrin αvβ3 during angiogenesis. J Clin Invest 1996, 98, 426-433.
66. 66. Nunez G, Clarke MF. The Bcl-2 family of proteins: regulators of cell death and survival. Trends Cell Biol 1994, 4, 399-405.
67. 67. Davis GE. Affinity of integrins for damaged extracellular matrix: αvβ3 binds to denatured collagen type-I through RGD sites. Biophys Res Commun 1992, 182, 1025-1031.